polycarbophil

Small moleculeexperimental

Polycarbophil calcium (INN) is a drug used as a stool stabilizer. Chemically, it is a synthetic polymer of polyacrylic acid cross-linked with divinyl glycol, with calcium as a counter-ion. — Wikipedia

Clinical trial activity

4 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
1

Earliest trial started Oct 1, 2010 (NCT01252524)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetOTHER

    Bulk forming laxative

  • Unspecified targetLaxative

    laxative

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
Yes

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • calcium polycarbophil
  • mitrolan
  • polycarbofil
  • polycarbophil
  • polycarbophil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04493333Phase 2Dec 31, 2020AMAG Pharmaceuticals, Inc., University of Arkansas
NCT02516202Phase 4Apr 1, 2016Group Health Cooperative, Harvard University, Kaiser Permanente, University of California, San Diego, University of Minnesota, University of Washington
NCT01984138Phase 2Sep 1, 2013Baylor University
NCT01252524N/AOct 1, 2010East Carolina University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AMAG Pharmaceuticals, Inc.For profit1012020
Baylor UniversityAcademic/Hospital1112013
East Carolina UniversityAcademic/Hospital1112010
Group Health CooperativeAcademic/Hospital1012016
Harvard UniversityAcademic/Hospital1012016
Kaiser PermanenteAcademic/Hospital1012016
University of ArkansasAcademic/Hospital1112020
University of California, San DiegoAcademic/Hospital1012016
University of MinnesotaAcademic/Hospital1012016
University of WashingtonAcademic/Hospital1112016
10 organizations
Page 1 / 1